| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L Chua, S A Chong, E Pang, V P Ng, Y H Cha. The effect of risperidone on cognitive functioning in a sample of Asian patients with schizophrenia in Singapore. Singapore medical journal. vol 42. issue 6. 2001-09-20. PMID:11547959. |
the effect of risperidone on cognitive functioning in a sample of asian patients with schizophrenia in singapore. |
2001-09-20 |
2023-08-12 |
Not clear |
| L Chua, S A Chong, E Pang, V P Ng, Y H Cha. The effect of risperidone on cognitive functioning in a sample of Asian patients with schizophrenia in Singapore. Singapore medical journal. vol 42. issue 6. 2001-09-20. PMID:11547959. |
to evaluate the effect of risperidone treatment on the cognitive functioning in a group of asian patients with schizophrenia |
2001-09-20 |
2023-08-12 |
Not clear |
| J M Azorin, R Spiegel, G Remington, J M Vanelle, J J Péré, M Giguere, I Bourdei. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. The American journal of psychiatry. vol 158. issue 8. 2001-08-30. PMID:11481167. |
a double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. |
2001-08-30 |
2023-08-12 |
Not clear |
| J M Azorin, R Spiegel, G Remington, J M Vanelle, J J Péré, M Giguere, I Bourdei. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. The American journal of psychiatry. vol 158. issue 8. 2001-08-30. PMID:11481167. |
this prospective, double-blind, multicenter, parallel-group study compared the efficacy and safety of therapeutic doses of clozapine and risperidone in patients with severe chronic schizophrenia and poor previous treatment response. |
2001-08-30 |
2023-08-12 |
Not clear |
| E Spina, A Avenoso, G Facciolà, M G Scordo, M Ancione, A Madi. Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine. Therapeutic drug monitoring. vol 23. issue 3. 2001-08-23. PMID:11360029. |
the effects of paroxetine on steady-state plasma concentrations of risperidone and its active metabolite 9-hydroxyrisperidone (9-oh-risperidone) were studied in 10 patients with schizophrenia or schizoaffective disorder. |
2001-08-23 |
2023-08-12 |
Not clear |
| R Ganguli, J S Brar, Z Ayrto. Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. Schizophrenia research. vol 49. issue 3. 2001-08-09. PMID:11356587. |
weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. |
2001-08-09 |
2023-08-12 |
Not clear |
| R Ganguli, J S Brar, Z Ayrto. Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. Schizophrenia research. vol 49. issue 3. 2001-08-09. PMID:11356587. |
in order to determine whether newer antipsychotic agents differ from each other with respect to weight gain, we compared two cohorts of patients with dsm-iv schizophrenia who had newly started treatment with either risperidone or olanzapine. |
2001-08-09 |
2023-08-12 |
Not clear |
| G Remington, I Khramo. Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics. Progress in neuro-psychopharmacology & biological psychiatry. vol 25. issue 2. 2001-08-02. PMID:11294482. |
patients with schizophrenia who had been stabilized on their antipsychotic medication and subsequently maintained on it for a period of at least 18 months were identified: clozapine (n=15); risperidone (n=15); depot conventional (n=18); oral conventional (n=18). |
2001-08-02 |
2023-08-12 |
Not clear |
| D L Kelly, M W Nelson, R C Love, Y Yu, R R Conle. Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. Psychiatric services (Washington, D.C.). vol 52. issue 5. 2001-08-02. PMID:11331805. |
comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. |
2001-08-02 |
2023-08-12 |
Not clear |
| D L Kelly, M W Nelson, R C Love, Y Yu, R R Conle. Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. Psychiatric services (Washington, D.C.). vol 52. issue 5. 2001-08-02. PMID:11331805. |
this study compared the discharge rates and drug costs of 789 patients with schizophrenia or schizoaffective disorder who began pharmacotherapy with olanzapine or risperidone between july 1997 and june 1998. |
2001-08-02 |
2023-08-12 |
Not clear |
| D L Kelly, M W Nelson, R C Love, Y Yu, R R Conle. Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. Psychiatric services (Washington, D.C.). vol 52. issue 5. 2001-08-02. PMID:11331805. |
these data suggest that among inpatients with schizophrenia or schizoaffective disorder, use of risperidone results in a higher discharge rate and a lower drug cost than use of olanzapine. |
2001-08-02 |
2023-08-12 |
Not clear |
| C R Alves, M T Silv. Facilitation of latent inhibition by the atypical antipsychotic risperidone. Pharmacology, biochemistry, and behavior. vol 68. issue 3. 2001-07-19. PMID:11325405. |
the facilitation of li by risperidone gives additional support to the li paradigm as an animal model of schizophrenia. |
2001-07-19 |
2023-08-12 |
rat |
| J A Sacristán, J C Gómez, F Ferre, J Gascón, A Pérez Bravo, J M Olivare. [Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: results of an observational study]. Actas espanolas de psiquiatria. vol 29. issue 1. 2001-07-19. PMID:11333516. |
to analyze the incidence of extrapyramidal symptoms (eps) and the concomitant use of anticholinergic drugs in outpatients diagnosed of schizophrenia treated with olanzapine (olz) in comparison with haloperidol (hal) and risperidone (ris) under routine clinical practice conditions. |
2001-07-19 |
2023-08-12 |
Not clear |
| S Hirose, C R Ashby, M J Mill. Effectiveness of ECT combined with risperidone against aggression in schizophrenia. The journal of ECT. vol 17. issue 1. 2001-07-12. PMID:11281510. |
effectiveness of ect combined with risperidone against aggression in schizophrenia. |
2001-07-12 |
2023-08-12 |
Not clear |
| S M Gilbody, A M Bagnall, L Duggan, A Tuunaine. Risperidone versus other atypical antipsychotic medication for schizophrenia. The Cochrane database of systematic reviews. issue 3. 2001-07-05. PMID:10908551. |
risperidone versus other atypical antipsychotic medication for schizophrenia. |
2001-07-05 |
2023-08-12 |
Not clear |
| M C Mauri, V Laini, L Boscati, R Rudelli, V Salvi, R Orlandi, P Pap. Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels. European psychiatry : the journal of the Association of European Psychiatrists. vol 16. issue 1. 2001-06-21. PMID:11246293. |
long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels. |
2001-06-21 |
2023-08-12 |
Not clear |
| B R Basson, B J Kinon, C C Taylor, K A Szymanski, J A Gilmore, G D Tollefso. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. The Journal of clinical psychiatry. vol 62. issue 4. 2001-06-14. PMID:11379836. |
factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. |
2001-06-14 |
2023-08-12 |
Not clear |
| B R Basson, B J Kinon, C C Taylor, K A Szymanski, J A Gilmore, G D Tollefso. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. The Journal of clinical psychiatry. vol 62. issue 4. 2001-06-14. PMID:11379836. |
clinical factors predicting weight change in patients with schizophrenia and related disorders during acute treatment with the antipsychotic drugs olanzapine, risperidone, and haloperidol were sought through retrospective analyses. |
2001-06-14 |
2023-08-12 |
Not clear |
| D D Miller, N C Andreasen, D S O'Leary, G L Watkins, L L Boles Ponto, R D Hichw. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological psychiatry. vol 49. issue 8. 2001-06-07. PMID:11313038. |
comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. |
2001-06-07 |
2023-08-12 |
Not clear |
| D D Miller, N C Andreasen, D S O'Leary, G L Watkins, L L Boles Ponto, R D Hichw. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological psychiatry. vol 49. issue 8. 2001-06-07. PMID:11313038. |
atypical antipsychotics, such as risperidone, have been shown to be more effective for the treatment of the symptoms of schizophrenia and have a greater beneficial effect on neurocognition compared to the conventional antipsychotics. |
2001-06-07 |
2023-08-12 |
Not clear |